|
[1]
|
Targeting the CD74 signaling axis suppresses inflammation and rescues defective hematopoiesis in
RUNX1
-familial platelet disorder
Science Translational Medicine,
2025
DOI:10.1126/scitranslmed.adn9832
|
|
|
|
|
[2]
|
Altered platelet-megakaryocyte endocytosis and trafficking of albumin and fibrinogen in RUNX1 haplodeficiency
Blood Advances,
2024
DOI:10.1182/bloodadvances.2023011098
|
|
|
|
|
[3]
|
Altered platelet-megakaryocyte endocytosis and trafficking of albumin and fibrinogen in RUNX1 haplodeficiency
Blood Advances,
2024
DOI:10.1182/bloodadvances.2023011098
|
|
|
|
|
[4]
|
Natural history study of patients with familial platelet disorder with associated myeloid malignancy
Blood,
2023
DOI:10.1182/blood.2023019746
|
|
|
|
|
[5]
|
Conduite à tenir devant une prédisposition génétique aux hémopathies malignes chez un patient candidat à l’allogreffe de cellules souches hématopoïétiques (CSH) : recommandations de la SFGM-TC
Bulletin du Cancer,
2023
DOI:10.1016/j.bulcan.2022.09.002
|
|
|
|
|
[6]
|
Conduite à tenir devant une prédisposition génétique aux hémopathies malignes chez un patient candidat à l’allogreffe de cellules souches hématopoïétiques (CSH) : recommandations de la SFGM-TC
Bulletin du Cancer,
2023
DOI:10.1016/j.bulcan.2022.09.002
|
|
|
|
|
[7]
|
Molecular Basis of Hematological Disease Caused by Inherited or Acquired RUNX1 Mutations
Experimental Hematology,
2022
DOI:10.1016/j.exphem.2022.03.009
|
|
|
|
|
[8]
|
Conduite à tenir devant une prédisposition génétique aux hémopathies malignes chez un patient candidat à l’allogreffe de cellules souches hématopoïétiques (CSH) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
Bulletin du Cancer,
2022
DOI:10.1016/j.bulcan.2022.09.002
|
|
|
|
|
[9]
|
Molecular Basis of Hematological Disease Caused by Inherited or Acquired RUNX1 Mutations
Experimental Hematology,
2022
DOI:10.1016/j.exphem.2022.03.009
|
|
|
|
|
[10]
|
Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice
Hematology/Oncology Clinics of North America,
2020
DOI:10.1016/j.hoc.2019.10.002
|
|
|
|
|
[11]
|
Runx1 negatively regulates inflammatory cytokine production by neutrophils in response to Toll-like receptor signaling
Blood Advances,
2020
DOI:10.1182/bloodadvances.2019000785
|
|
|
|
|
[12]
|
RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML
Blood Advances,
2020
DOI:10.1182/bloodadvances.2019000901
|
|
|
|
|
[13]
|
Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA)
Blood,
2020
DOI:10.1182/blood.2019000937
|
|
|
|
|
[14]
|
Progressive pigmented purpuric dermatosis and platelet delta storage pool deficiency in a child
Pediatric Blood & Cancer,
2019
DOI:10.1002/pbc.27748
|
|
|
|
|
[15]
|
Progressive pigmented purpuric dermatosis and platelet delta storage pool deficiency in a child
Pediatric Blood & Cancer,
2019
DOI:10.1002/pbc.27748
|
|
|
|
|
[16]
|
Recognition of familial myeloid neoplasia in adults
Seminars in Hematology,
2017
DOI:10.1053/j.seminhematol.2016.11.003
|
|
|
|
|
[17]
|
Role of RUNX1 in hematological malignancies
Blood,
2017
DOI:10.1182/blood-2016-10-687830
|
|
|
|
|
[18]
|
RUNX1 Mutations in Inherited and Sporadic Leukemia
Frontiers in Cell and Developmental Biology,
2017
DOI:10.3389/fcell.2017.00111
|
|
|
|
|
[19]
|
Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies
Blood,
2016
DOI:10.1182/blood-2015-10-676098
|
|
|
|